The 7980.T stock surged 50.17% intraday to JPY 1,347.00 on 03 Mar 2026 on the JPX, making Shigematsu Works Co., Ltd. a clear top gainer in early trading. Volume hit 523,500 shares versus an average of 19,059.00, a relative volume of 28.92, signalling aggressive buying. Traders cited stronger-than-expected company metrics and technical breakouts as drivers. We review the price action, valuation, Meyka grade, and short-term scenarios for investors.

Intraday price action and volume: 7980.T stock breakout

Shigematsu Works (7980.T) opened at JPY 1,347.00 and reached a day high of JPY 1,347.00, up from a previous close of JPY 897.00. The stock recorded 523,500.00 shares traded, well above the average volume of 19,059.00, indicating outsized participation.

Intraday momentum pushed price above its 50-day average of JPY 806.42 and 200-day average of JPY 803.61, a technical breakout that traders will watch for follow-through.

Fundamentals and valuation: earnings, PE and balance sheet

Shigematsu Reports EPS of 80.01 and a reported PE of 13.09, below the Healthcare sector average PE of 23.65, suggesting the stock remains relatively inexpensive on current profits. Key balance-sheet metrics include book value per share of JPY 1,263.52, cash per share of JPY 221.80, and debt to equity of 0.70, supporting solvency.

Margins are modest: gross margin 30.48% and net margin 4.70%, while return on equity is 8.01%. These figures connect earnings strength to today’s move but also underline operational limits for further multiple expansion.

Technical indicators and risk signals for 7980.T stock

Momentum readings show RSI at 84.90 and CCI at 221.49, both in overbought territory, and ADX at 52.40 signaling a strong trend. The average true range is 31.62, and Bollinger middle at JPY 849.70 indicates the current price is extended above volatility bands.

High relative volume with overbought oscillators raises the chance of a pullback. Short-term traders should watch support near JPY 1,230.00 (intraday low) and the 50-day moving average at JPY 806.42.

Meyka Grade & valuation note for 7980.T stock

Meyka AI rates 7980.T with a score out of 100: 74.01, Grade B+, Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

The company rating dated 2026-03-02 shows a mixed view: DCF and ROA scores are strong while leverage is a weakness. These inputs explain a constructive long-term view despite short-term volatility.

Scenario outlook and price targets for traders and investors

We present two scenarios. Bull case: sustained demand and margin expansion push a near-term target to JPY 1,600.00 (implied upside 18.79% from JPY 1,347.00). Bear case: profit taking and reversion to model forecasts place a conservative target near JPY 900.00 (implied downside 33.16%).

Analysts should treat intraday strength as entry opportunity only with clear stop-loss placement. Watch upcoming earnings announcement date 2026-05-08 for confirmation of earnings momentum.

Sector context and catalysts affecting 7980.T stock

Shigematsu operates in Healthcare: Medical – Instruments & Supplies, where sector performance is steady and average PE is 23.65. The company’s protective-equipment sales can benefit from cyclical demand and regulatory safety spending.

Catalysts to monitor include order backlog updates, domestic safety equipment tenders, and changes in export demand. Sector comparatives point to valuation upside if revenue growth accelerates.

Final Thoughts

Intraday, the 7980.T stock rose 50.17% to JPY 1,347.00 on 03 Mar 2026 on the JPX driven by heavy volume and positive fundamentals. Short-term technicals are overbought, so traders face elevated pullback risk; support sits near JPY 1,230.00 and the 50-day average at JPY 806.42. Meyka AI’s forecast model projects a monthly price of JPY 886.72 and a yearly price of JPY 731.38, implying downside of -34.19% to the monthly figure and -45.73% to the yearly figure from the current level of JPY 1,347.00. These model-based projections are not guarantees. Investors should weigh the stock’s healthy EPS of 80.01, modest PE of 13.09, and a Meyka Grade B+ (74.01) against the volatility shown today. For active positions, use tight risk controls; for longer-term investors, monitor earnings on 2026-05-08 as the next key confirmation point.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.